Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00837 |
| Species: | Homo sapiens |
| Position : | chr8:128264000-128277000 |
| Year: | 2024 |
| Title: | Selective Enhancer Gain-of-Function Deregulates MYC Expression in Multiple Myeloma. |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | plasma cell myeloma |
| PMID: | 39312195 |
| MONDO: | MONDO:0009693 |
| Tissue: | blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | ANBL-6 |
| CVCL ID: | CVCL_5425 |
| Cell Type: | plasma cell |
| Cell Ontology ID: | CL:0000786 |
| Experiment Type: | Enhancer activity assay; TF binding assay; Functional perturbation assay; Chromatin interaction assay |
| High Throughput Method: | Pooled CRISPRi tiling screen; H3K27ac ChIP-seq; MAF ChIP-seq; Micro-C |
| Low Throughput Method: | Individual CRISPRi; CRISPR-Cas9 MAF-binding-site mutagenesis; Dual-luciferase reporter assay; qRT-PCR |
| Target gene : | MYC |
| TF name : | MAF |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| MAF | AP-1 transcription factor network | pid | 71 |
| MAF | C-MYB transcription factor network | pid | 87 |
| MAF | Calcineurin-regulated NFAT-dependent transcription in lymphocytes | pid | 50 |
| MAF | Kaposi sarcoma-associated herpesvirus | mirtarbase | 13 |
| MAF | Hs_TYROBP_Causal_Network_WP3945_90843 | wikipathways | 54 |